Polaryx Therapeutics, Inc. PLYX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $679K— | —— | —— | —— | $4.72M+571% | ||
| $1.28M— | —— | —— | —— | $336K-12.8% | ||
| $1.96M— | —— | —— | —— | $5.05M+364% | ||
| $1.96M— | —— | —— | —— | $5.05M+364% | ||
| -$1.96M— | —— | —— | —— | -$5.05M-364% | ||
| -$2.54M— | —— | —— | —— | -$5.05M+33.4% | ||
| -$0.05— | —— | —— | —— | -$0.11+50.6% | ||
| -$0.05— | —— | —— | —— | -$0.11+50.6% | ||
| 47.2M+4.0% | 45.4M— | —— | —— | 44.3M+29.6% | ||
| 47.2M+4.0% | 45.4M— | —— | —— | 44.3M+29.6% | ||
| $586K+101% | $291K0.0% | $291K0.0% | $291K0.0% | $291K— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Polaryx Therapeutics, Inc. profitable?
- Polaryx Therapeutics, Inc. is not currently profitable: it reported a net loss of $22.8M over the trailing twelve months.
- What is Polaryx Therapeutics, Inc. 's earnings per share?
- Polaryx Therapeutics, Inc. 's diluted EPS over the trailing twelve months is $-0.60.
- Where does Polaryx Therapeutics, Inc. 's income statement data come from?
- Every line is extracted from Polaryx Therapeutics, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.